Cardlytics (NASDAQ:CDLX) Trading Up 4.9% – Should You Buy?

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) shares rose 4.9% on Tuesday . The company traded as high as $1.12 and last traded at $1.08. Approximately 1,038,934 shares changed hands during trading, an increase of 43% from the average daily volume of 725,265 shares. The stock had previously closed at $1.03.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on CDLX. Weiss Ratings restated a “sell (d-)” rating on shares of Cardlytics in a research note on Monday. Wall Street Zen lowered Cardlytics from a “hold” rating to a “sell” rating in a report on Saturday, November 8th. Three analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Cardlytics currently has a consensus rating of “Reduce” and a consensus target price of $2.25.

Read Our Latest Research Report on CDLX

Cardlytics Price Performance

The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 2.87. The stock’s 50 day moving average price is $1.44 and its two-hundred day moving average price is $1.63. The stock has a market cap of $58.38 million, a price-to-earnings ratio of -0.51 and a beta of 1.09.

Cardlytics (NASDAQ:CDLXGet Free Report) last posted its quarterly earnings results on Wednesday, November 5th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.08. The company had revenue of $52.03 million for the quarter, compared to analyst estimates of $56.64 million. Cardlytics had a negative net margin of 44.12% and a negative return on equity of 235.70%. Equities research analysts forecast that Cardlytics, Inc. will post -1.52 EPS for the current fiscal year.

Institutional Trading of Cardlytics

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Personalized Indexing Management LLC acquired a new position in Cardlytics in the third quarter valued at approximately $26,000. Catalyst Funds Management Pty Ltd acquired a new stake in shares of Cardlytics during the 2nd quarter worth approximately $32,000. Post Resch Tallon Group Inc. increased its holdings in shares of Cardlytics by 100.0% during the 2nd quarter. Post Resch Tallon Group Inc. now owns 20,000 shares of the company’s stock valued at $33,000 after purchasing an additional 10,000 shares in the last quarter. Sand Hill Global Advisors LLC acquired a new position in shares of Cardlytics in the 2nd quarter valued at $35,000. Finally, Jump Financial LLC acquired a new position in shares of Cardlytics in the 1st quarter valued at $41,000. 68.10% of the stock is owned by institutional investors and hedge funds.

Cardlytics Company Profile

(Get Free Report)

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.

Recommended Stories

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.